Buy & Sell Biogen Inc (BIIB) – Biogen Inc Price Today
Aura AI Summary
Key Stats
- $28.49BMarket Cap
- HealthSector
- -12.22%3M Drawdown
- $30.77BEnterprise Value
- -Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 108 daysTypical Hold Time
Biogen Inc (BIIB) is currently valued at a market capitalization of $28.49B, with an enterprise value of $30.77B. Over the past 52 weeks, Biogen Inc has traded between a low of $122.68 and a high of $204.53, highlighting its annual price range. Over the past three months, Biogen Inc has recorded a drawdown of -12.22%, reflecting recent price volatility. On average, investors hold Biogen Inc for approximately 108 days, indicating typical investor behavior on the platform.
About Biogen Inc
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Most Recent News
Bill C-22 sparks global tech backlash over risks to Canada's digital economy and privacy.
Canada's proposed Bill C-22 faces strong opposition from major tech firms like Meta, Apple, and Signal, as well as VPN providers, due to concerns it could force companies to weaken encryption and compromise digital privacy. Industry leaders warn this...
Bill C-22 risks harming Quebec's tech economy by driving away investments and data centers.
Bill C-22 in Canada faces strong opposition from tech leaders and experts who warn it threatens the digital economy by undermining data privacy and encryption. Quebec's tech sector, especially in AI and cloud infrastructure, could lose investments, t...
Sandisk stock soars 476% in 2026 amid AI-driven storage demand but may face a technical pullback soon.
Sandisk's stock has surged 476% in 2026, driven by strong demand for storage linked to the AI boom and impressive revenue growth, including a 97% quarter-over-quarter increase to $5.9 billion. The company boasts high profit margins and optimistic Wal...
